Achmea Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
20,536
-323,595
-94% -$26.1M 0.04% 105
2026
Q1
$29.8M Buy
344,131
+7,157
+2% +$686K 0.79% 36
2025
Q4
$32.4M Sell
336,974
-18,107
-5% -$1.76M 0.83% 30
2025
Q3
$33.8M Sell
355,081
-1,139
-0.3% -$105K 0.42% 55
2025
Q2
$31.1M Buy
356,220
+21,408
+6% +$1.82M 0.4% 59
2025
Q1
$30.1M Buy
334,812
+142,788
+74% +$12.8M 0.44% 62
2024
Q4
$15.3M Buy
192,024
+1,248
+0.7% +$108K 0.25% 102
2024
Q3
$17.2M Buy
190,776
+20,907
+12% +$1.76M 0.28% 90
2024
Q2
$13.4M Sell
169,869
-9,441
-5% -$774K 0.24% 104
2024
Q1
$15.6M Buy
179,310
+97,197
+118% +$8.3M 0.3% 85
2023
Q4
$6.76M Hold
82,113
0.14% 175
2023
Q3
$6.43M Buy
82,113
+3,863
+5% +$323K 0.14% 169
2023
Q2
$6.89M Buy
78,250
+32,542
+71% +$2.8M 0.15% 158
2023
Q1
$3.69M Sell
45,708
-4,836
-10% -$394K 0.11% 213
2022
Q4
$3.68M Sell
50,544
-9,905
-16% -$803K 0.12% 199
2022
Q3
$4.88M Sell
60,449
-10,866
-15% -$977K 0.17% 144
2022
Q2
$6.4M Hold
71,315
0.21% 127
2022
Q1
$7.91M Buy
+71,315
New +$7.53M 0.21% 117
2021
Q4
Sell
-83,630
Closed -$10.5M 405
2021
Q3
$10.5M Sell
83,630
-2,378
-3% -$308K 0.32% 80
2021
Q2
$10.7M Buy
86,008
+1,877
+2% +$236K 0.36% 59
2021
Q1
$9.94M Sell
84,131
-2,096
-2% -$246K 0.35% 68
2020
Q4
$10.1M Sell
86,227
-24,154
-22% -$2.66M 0.36% 59
2020
Q3
$11.5M Sell
110,381
-376,232
-77% -$37.8M 0.48% 43
2020
Q2
$44.6M Sell
486,613
-2,901
-0.6% -$278K 1.51% 16
2020
Q1
$44.1M Buy
+489,514
New +$52.1M 2.02% 12
2019
Q4
Sell
-139,625
Closed -$15.2M 545
2019
Q3
$15.2M Buy
139,625
+3,981
+3% +$415K 0.6% 35
2019
Q2
$13.2M Buy
+135,644
New +$12.4M 0.5% 43
2018
Q4
Sell
-49,152
Closed -$4.83M 478
2018
Q3
$4.83M Buy
49,152
+33,558
+215% +$3.1M 0.18% 131
2018
Q2
$1.33M Hold
15,594
0.05% 332
2018
Q1
$1.25M Hold
15,594
0.04% 362
2017
Q4
$1.26M Sell
15,594
-2,705
-15% -$217K 0.04% 361
2017
Q3
$1.42M Sell
18,299
-7,184
-28% -$596K 0.08% 278
2017
Q2
$2.26M Sell
25,483
-91,051
-78% -$7.68M 0.14% 207
2017
Q1
$9.39M Buy
+116,534
New +$9.1M 0.44% 48

Other funds holding MDT

Achmea Investment Management's MDT Position: Q2 2026 in Review

Achmea Investment Management reduced its Medtronic (MDT) stake by 94% in Q2 2026, selling an estimated $26.1M and leaving 20,536 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #105.

Achmea Investment Management first reported a position in MDT in Q1 2017 and has held it in 34 quarters since. The position peaked at $44.6M in Q2 2020. 397 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Achmea Investment Management held 20,536 shares of Medtronic worth $1.61M as of Q2 2026.
  • Achmea Investment Management sold 323,595 Medtronic shares in Q2 2026, an estimated $26.1M.
  • Medtronic made up 0.04% of Achmea Investment Management's portfolio in Q2 2026, its #105 holding.
  • Achmea Investment Management first reported a position in Medtronic in Q1 2017 and has held it in 34 quarters since.
  • Achmea Investment Management's Medtronic position peaked at $44.6M in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Achmea Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.